Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Websites for controlled drugs
-
Assuming that a url is only provided via a PAAB-approved APS, if a website is being designed for a controlled drug, are there any differences in what is allowable versus for a prescription product. For example, can the brand name be on the gate page, can there be a patient section (DIN gated) where the contents of a PAAB-approved Patient Brochure are provided? Are there any specific restrictions that affect controlled drugs when it comes to websites?
Thanks. -
Hey @charlton
Great question. You can provide a link to the HCP and to the patient. On the landing page, you can present the product name and the DIN login or HCP verification login. The site cannot link back to the parent company site or any site containing the PM. There should be no logo or promotional content on the pre-gate landing page. You also cannot use Search Engine Marketing (SEM).
